Ibrutinib and Venetoclax: Potential Combination for r/r CLL Ibrutinib and Venetoclax: Potential Combination for r/r CLL
Ibrutinib and venetoclax are already approved for the treatment of chronic lymphocytic leukemia, but new data suggest that using them together could be an option.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Health | Hematology | Leukemia